Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database
Brain and Behavior · 2025
DOI: 10.1002/brb3.70712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Sena Türkeş und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Antipsychotic Agents, Psychotic Disorders, Practice Patterns, Physicians', Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Psychotic disorders, affecting 3–7 per 1000 individuals, significantly impair mental functioning. Although antipsychotic medications represent the mainstay of treatment, prescribing practices can vary based on patient characteristics and across different countries. Currently, national epidemiological data on psychotropic prescribing patterns in Türkiye are lacking, and understanding these variations is crucial for informing treatment guidelines and optimizing patient care.
Methods
Data from the Turkish Prescription Information System (PIS) for the year 2019 were analyzed to evaluate antipsychotic prescribing patterns for psychotic disorders. Included were prescriptions for schizophrenia, other specified psychotic disorders not attributable to a substance or known physiological condition, and unspecified psychosis with the same exclusion criteria.
Results
Second‐generation antipsychotics (SGAs) constituted 80% of all prescriptions, making them the most frequently prescribed class in Türkiye. This finding is consistent with other national studies. Quetiapine was the most frequently prescribed SGA overall, although prescribing patterns varied by age group. Although SGAs were the most commonly prescribed class, typical antipsychotics or first‐generation antipsychotics (FGAs) remained in use, particularly haloperidol in patients aged ≥80 years.
Conclusions
This national study demonstrates the widespread use of SGAs in Türkiye, particularly quetiapine, while also highlighting the continued use of FGAs, especially haloperidol, in older adults. These findings highlight the need for further research on age‐specific prescribing practices and the development of tailored treatment guidelines. Furthermore, international comparisons of prescribing patterns should be conducted to identify potential variations and explore their underlying causes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Gazi University, Ankara, Türkiye.
- Department of Psychiatry, Faculty of Medicine, Gazi University, Ankara, Türkiye.
- Department of Medical Informatics, Sağlık Bilimleri University Gülhane Faculty of Medicine, Ankara, Türkiye.
- Institue of Public Health, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.
ORCID-Profile: Sena Türkeş, Aybeniz Civan Kahve, Taner Çin, Esra Şafak Yılmaz, Hakkı Gürsöz, Süreyya Barun
Zitieren
APA
Türkeş, S., Kahve, A. C., Çin, T., Yılmaz, E. Ş., Gürsöz, H., & Barun, S. (2025). Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database. Brain and Behavior. https://doi.org/10.1002/brb3.70712
Vancouver
Türkeş S, Kahve AC, Çin T, Yılmaz EŞ, Gürsöz H, Barun S. Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database. Brain and Behavior. 2025. doi:10.1002/brb3.70712
BibTeX
@article{Trke2025,
author = {Türkeş, Sena and Kahve, Aybeniz Civan and Çin, Taner and Yılmaz, Esra Şafak and Gürsöz, Hakkı and Barun, Süreyya},
title = {Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70712}
}
EUVIMED